TY - JOUR ID - 245664 TI - Evaluating of the Effects of Sub-MIC Concentrations of Gentamicin on Biofilm Formation in Clinical Isolates of Pseudomonas aeruginosa JO - Iranian Journal of Pathology JA - IJP LA - en SN - 1735-5303 AU - Yousefpour, Zahra AU - Davarzani, Fateme AU - Owlia, Parviz AD - Department of Microbiology, Faculty of Medicine. Shahed University, Tehran, Iran AD - Molecular Microbiology Research Center (MMRC), Faculty of Medicine, Shahed University, Tehran, Iran Y1 - 2021 PY - 2021 VL - 16 IS - 4 SP - 403 EP - 410 KW - biofilm KW - Pseudomonas aeruginosa KW - pelA KW - pslA DO - 10.30699/ijp.2021.524220.2584 N2 - Background & Objective: The ability of Pseudomonas aeruginosa to form biofilm has an important role in establishment of chronic phase of infections. Biofilm formation can be affected by antibiotics sub-MIC concentrations. The principal aim of the present study was to evaluate the effect of gentamicin at sub-MIC concentrations on biofilm formation in 100 Pseudomonas aeruginosa clinical isolates.Methods: Determination of minimal inhibitory concentration of gentamicin for clinical isolates was done using micro broth dilution method. The amount of biofilm formation in the treated and untreated isolates with gentamicin sub-MIC (1/2&1/4MIC) concentrations was evaluated using microtitre plate assay. pelA and pslA genes were detected in clinical isolates by PCR method.Results: 99% of clinical isolates were biofilm producer. Different changes in amountof biofilm formation were observed in the treated clinical isolates with sub-MIC concentrations of gentamicin. Two dominant changes were observed in 80% of clinical isolates. These concentrations had inhibitory effect on biofilm formation in 46.4% of isolates and caused a significant decrease in its amount. While in 31.3% of the isolates, the biofilm formation was significantly increased. The frequency of pelA and pslA genes among clinical isolates was 100%. Conclusion: gentamicin sub-MIC concentrations cause different changes on biofilm formation of Pseudomonas aeruginosa clinical isolates. Therefore, further studies are needed for discovering new treatment strategies and using sub-MIC concentrations of the antibiotic in prevention and treatment of Pseudomonas aeruginosa infections.  UR - https://ijp.iranpath.org/article_245664.html L1 - https://ijp.iranpath.org/article_245664_8bfb4ad8bcc7bb2df31d9675d6e0f2cd.pdf ER -